Skip navigation

COVID-19 vaccines

Four vaccines have currently received an authorisation for use in Estonia and Europe. The COVID-19 vaccines are all equally safe, effective and high quality. No concessions were made in the efficacy and safety of the COVID-19 vaccines when they applied for expedited marketing authorisations. The studies and monitoring the safety of the vaccines will continue even after a marketing authorisation has been granted.

How many and which vaccines have been ordered for Estonia

For buying the vaccines, Estonia is participating in the European Union joint procurement which has been joined by all member states. Altogether, the vaccines of eight vaccine manufacturers are in the European Commission joint procurement portfolio of vaccines. As of right now, Estonia has joined the pre-purchasing agreements with five manufacturers but the government has also given its approval for joining the contracts with other manufacturers.

Along with the Valneva contract that has been added to the joint European Union vaccine portfolio, Estonia has the possibility to acquire 5,229,362 doses altogether, for 2,764,681 people.

Table: “The vaccines in the joint European procurement (the ones that Estonia has already joined are bolded)”
Vaccine Vaccine type Marketing authorization or the current state of the application process How many people it has been ordered for
Pfizer/BioNTech Comirnaty mRNA Conditional marketing authorisation from December 21 857 214
Moderna mRNA Conditional marketing authorisation from January 6 122 134
Vaxzevria (AstraZeneca) Adenovirus Conditional marketing authorisation from January 29 665 000
Janssen Pharmaceutica (Johnson & Johnson) Adenovirus Conditional marketing authorisation from March 11 300 000
Curevac mRNA No marketing authorisation yet 329 692
Sanofi Protein-based No marketing authorisation yet 300 000
Novavax Protein-based No marketing authorisation yet 146 542
Valneva Inactivated No marketing authorisation yet 44 000

COVID-19 vaccines information

  • Overview of the vaccines that are currently being reviewed at the European Medicines Agency can be found here.
  • Read here how COVID-19 vaccines are developed evaluated, approved and monitored.

Frequently asked questions about COVID-19 vaccines

Last updated: 22. June 2021, 17:14

Register for vaccinating
Scroll to top